Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Authors: Brahmer, Julie1 brahmju@jhmi.edu, Reckamp, Karen L.2, Baas, Paul3, Crinò, Lucio4, Eberhardt, Wilfried E. E.5,6, Poddubskaya, Elena7, Antonia, Scott8, Pluzanski, Adam9, Vokes, Everett E.10, Holgado, Esther11, Waterhouse, David12, Ready, Neal13, Gainor, Justin14, Frontera, Osvaldo Arén15, Havel, Libor16, Steins, Martin17, Garassino, Marina C.18, Aerts, Joachim G.19, Domine, Manuel20, Paz-Ares, Luis21
Source: New England Journal of Medicine. 7/9/2015, Vol. 373 Issue 2, p123-135. 13p.
Database: Academic Search Ultimate
Description
ISSN:00284793
DOI:10.1056/NEJMoa1504627